Provider Training + Interactive Texting for HPV Vaccination

(Text&Talk Trial)

Recruiting at 1 trial location

Overseen By Marta D Hansen, MBA

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: University of Florida

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

21110 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living in Florida.

Research Team

Stephanie Staras, PhD

Principal Investigator

University of Florida

Eligibility Criteria

This trial is for parents of 10- to 12-year-olds who haven't had the HPV vaccine and visit participating Florida clinics. It's also for providers giving primary care to this age group at these clinics. Adolescents outside this age range, those opted-out of texts, or without a cell number on file can't join.

Inclusion Criteria

I am a primary care provider for 11 to 12-year-olds at a participating clinic.

I am the parent of a teenager who meets the trial criteria.

I am between 10 and 12 years old and have visited a clinic in the last two years.

Exclusion Criteria

My guardians or I are willing to consent to participation.

I am not an adolescent.

I previously chose not to receive text messages.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Delivery

Clinicians receive training and parents receive text messages as part of the intervention

12 months

Training sessions via Zoom, text messages sent periodically

Follow-up

Participants are monitored for HPV vaccination initiation and up-to-date status

24 months

Treatment Details

Interventions

• Brief Provider Training - Benefits Approach
• Brief Provider Training - Bundled Approach
• Parent Interactive Text Message - Benefits Approach
• Parent Interactive Text Message - Bundled Approach

Trial Overview The study tests two methods to increase HPV vaccination rates: one sends educational text messages to parents, and the other provides brief training to clinicians. The goal is to see if these approaches encourage vaccinations in 11-12 year olds.

Participant Groups

Group I: Deferred-clinician training and bundled text messages Experimental Treatment 1 Intervention

Clinicians will receive training after the study and parents will receive bundled text messages.

Group II: Deferred-clinician training and benefits text messages Experimental Treatment 1 Intervention

Clinicians will receive training after the study and parents will receive benefits text messages.

Group III: Bundled clinician training and no text messages Experimental Treatment 1 Intervention

Clinicians will receive bundled approach training and parents will not receive any intervention text messages.

Group IV: Bundled clinician training and bundled text messages Experimental Treatment 2 Interventions

Clinicians will receive bundled approach training and parents will receive bundled text messages.

Group V: Bundled clinician training and benefits text messages Experimental Treatment 2 Interventions

Clinicians will receive bundled approach training and parents will receive benefits text messages.

Group VI: Benefits clinician training and no text messages Experimental Treatment 1 Intervention

Clinicians will receive benefits approach training and parents will not receive any intervention text messages.

Group VII: Benefits clinician training and bundled text messages Experimental Treatment 2 Interventions

Clinicians will receive benefits approach training and parents will receive bundled text messages.

Group VIII: Benefits clinician training and benefits text messages Experimental Treatment 2 Interventions

Clinicians will receive benefits approach training and parents will receive benefits text messages.

Group IX: Deferred-clinician training and no text messages Active Control 1 Intervention

Clinicians will receive training after the study and parents will not receive intervention text messages.

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials

1,428

Recruited

987,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+